nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—ALB—ulcerative colitis	0.411	1	CbGaD
Gliclazide—CYP2C19—Nicotine—ulcerative colitis	0.0476	0.173	CbGbCtD
Gliclazide—ALB—Prednisone—ulcerative colitis	0.0457	0.166	CbGbCtD
Gliclazide—CYP2C19—Cholecalciferol—ulcerative colitis	0.0427	0.156	CbGbCtD
Gliclazide—CYP2C9—Nicotine—ulcerative colitis	0.0396	0.144	CbGbCtD
Gliclazide—CYP2C9—Cholecalciferol—ulcerative colitis	0.0355	0.129	CbGbCtD
Gliclazide—CYP2C19—Prednisone—ulcerative colitis	0.0296	0.108	CbGbCtD
Gliclazide—CYP2C19—Dexamethasone—ulcerative colitis	0.0185	0.0673	CbGbCtD
Gliclazide—CYP2C9—Dexamethasone—ulcerative colitis	0.0154	0.056	CbGbCtD
Gliclazide—Glipizide—PPARG—ulcerative colitis	0.0017	0.465	CrCbGaD
Gliclazide—Chlorpropamide—PTGS1—ulcerative colitis	0.000906	0.248	CrCbGaD
Gliclazide—VEGFA—Betamethasone—Budesonide—ulcerative colitis	0.000673	0.131	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Budesonide—ulcerative colitis	0.000673	0.131	CbGdCrCtD
Gliclazide—Chlorpropamide—ABCB1—ulcerative colitis	0.00044	0.121	CrCbGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000359	0.00476	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—HLA-DRB1—ulcerative colitis	0.000355	0.00471	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—MPO—ulcerative colitis	0.000353	0.00468	CbGpPWpGaD
Gliclazide—VEGFA—Betamethasone—Hydrocortisone—ulcerative colitis	0.000345	0.0672	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000345	0.0672	CbGdCrCtD
Gliclazide—VEGFA—SHP2 signaling—JAK2—ulcerative colitis	0.000338	0.00449	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by TCPTP—STAT3—ulcerative colitis	0.000334	0.00443	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	0.000333	0.00441	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—IFNG—ulcerative colitis	0.000332	0.0044	CbGpPWpGaD
Gliclazide—VEGFA—Dexamethasone—Methylprednisolone—ulcerative colitis	0.000325	0.0634	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Methylprednisolone—ulcerative colitis	0.000325	0.0634	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Betamethasone—ulcerative colitis	0.00032	0.0624	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Dexamethasone—ulcerative colitis	0.00032	0.0624	CbGdCrCtD
Gliclazide—VEGFA—Bladder Cancer—TP53—ulcerative colitis	0.000313	0.00415	CbGpPWpGaD
Gliclazide—VEGFA—Dexamethasone—Triamcinolone—ulcerative colitis	0.000313	0.061	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Triamcinolone—ulcerative colitis	0.000313	0.061	CbGdCrCtD
Gliclazide—Glyburide—ALB—ulcerative colitis	0.000312	0.0853	CrCbGaD
Gliclazide—VEGFA—Axon guidance—LAMB1—ulcerative colitis	0.000311	0.00412	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—ARPC2—ulcerative colitis	0.00031	0.00411	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—JAK2—ulcerative colitis	0.000309	0.0041	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—NR5A2—ulcerative colitis	0.000301	0.00399	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—RELA—ulcerative colitis	0.000299	0.00397	CbGpPWpGaD
Gliclazide—Glyburide—ABCB1—ulcerative colitis	0.000297	0.0814	CrCbGaD
Gliclazide—VEGFA—Betamethasone—Prednisone—ulcerative colitis	0.000297	0.0579	CbGdCrCtD
Gliclazide—VEGFA—Dexamethasone—Prednisone—ulcerative colitis	0.000297	0.0579	CbGdCrCtD
Gliclazide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000297	0.00393	CbGpPWpGaD
Gliclazide—CYP2C19—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000296	0.00393	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—IL2—ulcerative colitis	0.000295	0.00391	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000293	0.00388	CbGpPWpGaD
Gliclazide—VEGFA—Dexamethasone—Prednisolone—ulcerative colitis	0.00029	0.0565	CbGdCrCtD
Gliclazide—VEGFA—Betamethasone—Prednisolone—ulcerative colitis	0.00029	0.0565	CbGdCrCtD
Gliclazide—ALB—Folate Metabolism—MPO—ulcerative colitis	0.000287	0.00381	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—ALB—ulcerative colitis	0.000281	0.00373	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000272	0.00361	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000272	0.00361	CbGpPWpGaD
Gliclazide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.00027	0.00359	CbGpPWpGaD
Gliclazide—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.00027	0.00358	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—ALB—ulcerative colitis	0.000268	0.00356	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—TGFB1—ulcerative colitis	0.000268	0.00355	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR2 mediated cell proliferation—IL6—ulcerative colitis	0.000266	0.00353	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IFNG—ulcerative colitis	0.000259	0.00344	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	0.000259	0.00343	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—MMP9—ulcerative colitis	0.000258	0.00342	CbGpPWpGaD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000258	0.00342	CbGpPWpGaD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000257	0.00341	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	0.000257	0.0034	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.000256	0.00339	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—NFKB1—ulcerative colitis	0.000252	0.00335	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—CXCL8—ulcerative colitis	0.000241	0.0032	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—CALM3—ulcerative colitis	0.000233	0.00309	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IL1B—ulcerative colitis	0.000231	0.00307	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—IL2—ulcerative colitis	0.00023	0.00306	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000228	0.00303	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—STAT3—ulcerative colitis	0.000227	0.00301	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—CALM3—ulcerative colitis	0.000226	0.003	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	0.000224	0.00297	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—MMP1—ulcerative colitis	0.000223	0.00296	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—LAMB1—ulcerative colitis	0.000222	0.00294	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—TGFB1—ulcerative colitis	0.000213	0.00282	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.00021	0.00279	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000208	0.00275	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—JAK2—ulcerative colitis	0.000207	0.00275	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—CALM3—ulcerative colitis	0.000204	0.00271	CbGpPWpGaD
Gliclazide—VEGFA—Differentiation Pathway—IL6—ulcerative colitis	0.000202	0.00268	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—JAK2—ulcerative colitis	0.000196	0.0026	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	0.000194	0.00258	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TCF4—ulcerative colitis	0.000194	0.00257	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—GNA12—ulcerative colitis	0.00019	0.00252	CbGpPWpGaD
Gliclazide—VEGFA—EPH-Ephrin signaling—MMP9—ulcerative colitis	0.00019	0.00252	CbGpPWpGaD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000189	0.00251	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—ITGAL—ulcerative colitis	0.000187	0.00247	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—CRP—ulcerative colitis	0.000186	0.00246	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—TGFB1—ulcerative colitis	0.00018	0.00238	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CDH1—ulcerative colitis	0.00018	0.00238	CbGpPWpGaD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000179	0.00238	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—TGFB1—ulcerative colitis	0.000178	0.00236	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—IL6—ulcerative colitis	0.000173	0.0023	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TP53—ulcerative colitis	0.000173	0.00229	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000172	0.00229	CbGpPWpGaD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000172	0.00229	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PROCR—ulcerative colitis	0.000172	0.00228	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	0.000171	0.00226	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	0.00017	0.00225	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000169	0.00225	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—ADCY5—ulcerative colitis	0.000169	0.00224	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—HNF4A—ulcerative colitis	0.000168	0.00223	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—TNF—ulcerative colitis	0.000168	0.00223	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—ADCY5—ulcerative colitis	0.000164	0.00217	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CHP1—ulcerative colitis	0.000156	0.00207	CbGpPWpGaD
Gliclazide—CYP2C19—Melatonin metabolism and effects—NFKB1—ulcerative colitis	0.000152	0.00202	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CHP1—ulcerative colitis	0.000151	0.00201	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—CRP—ulcerative colitis	0.000151	0.002	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000149	0.00197	CbGpPWpGaD
Gliclazide—Diarrhoea—Azathioprine—ulcerative colitis	0.000142	0.000616	CcSEcCtD
Gliclazide—Discomfort—Prednisolone—ulcerative colitis	0.000141	0.000615	CcSEcCtD
Gliclazide—Angioedema—Triamcinolone—ulcerative colitis	0.000141	0.000615	CcSEcCtD
Gliclazide—Angioedema—Methylprednisolone—ulcerative colitis	0.000141	0.000613	CcSEcCtD
Gliclazide—Erythema—Betamethasone—ulcerative colitis	0.00014	0.00061	CcSEcCtD
Gliclazide—Erythema—Dexamethasone—ulcerative colitis	0.00014	0.00061	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.00014	0.00186	CbGpPWpGaD
Gliclazide—Myalgia—Hydrocortisone—ulcerative colitis	0.00014	0.000608	CcSEcCtD
Gliclazide—Malaise—Triamcinolone—ulcerative colitis	0.000139	0.000607	CcSEcCtD
Gliclazide—Anxiety—Hydrocortisone—ulcerative colitis	0.000139	0.000606	CcSEcCtD
Gliclazide—Malaise—Methylprednisolone—ulcerative colitis	0.000139	0.000605	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—ICAM1—ulcerative colitis	0.000139	0.00184	CbGpPWpGaD
Gliclazide—Hypersensitivity—Mesalazine—ulcerative colitis	0.000139	0.000604	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000139	0.000604	CcSEcCtD
Gliclazide—Discomfort—Hydrocortisone—ulcerative colitis	0.000138	0.000601	CcSEcCtD
Gliclazide—Nausea—Budesonide—ulcerative colitis	0.000138	0.000599	CcSEcCtD
Gliclazide—Dizziness—Azathioprine—ulcerative colitis	0.000137	0.000595	CcSEcCtD
Gliclazide—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000136	0.000591	CcSEcCtD
Gliclazide—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000136	0.00059	CcSEcCtD
Gliclazide—Asthenia—Mesalazine—ulcerative colitis	0.000135	0.000588	CcSEcCtD
Gliclazide—Cough—Triamcinolone—ulcerative colitis	0.000135	0.000587	CcSEcCtD
Gliclazide—ABCC8—Metabolism—DLD—ulcerative colitis	0.000135	0.00179	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.000134	0.00178	CbGpPWpGaD
Gliclazide—Convulsion—Triamcinolone—ulcerative colitis	0.000134	0.000583	CcSEcCtD
Gliclazide—Tachycardia—Prednisolone—ulcerative colitis	0.000134	0.000583	CcSEcCtD
Gliclazide—Convulsion—Methylprednisolone—ulcerative colitis	0.000134	0.000581	CcSEcCtD
Gliclazide—Hypertension—Triamcinolone—ulcerative colitis	0.000134	0.000581	CcSEcCtD
Gliclazide—Pruritus—Mesalazine—ulcerative colitis	0.000133	0.00058	CcSEcCtD
Gliclazide—Hypertension—Methylprednisolone—ulcerative colitis	0.000133	0.000579	CcSEcCtD
Gliclazide—Infection—Hydrocortisone—ulcerative colitis	0.000133	0.000579	CcSEcCtD
Gliclazide—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000133	0.000577	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—CALM3—ulcerative colitis	0.000132	0.00175	CbGpPWpGaD
Gliclazide—Myalgia—Triamcinolone—ulcerative colitis	0.000132	0.000573	CcSEcCtD
Gliclazide—Vomiting—Azathioprine—ulcerative colitis	0.000132	0.000572	CcSEcCtD
Gliclazide—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000131	0.000572	CcSEcCtD
Gliclazide—Arthralgia—Methylprednisolone—ulcerative colitis	0.000131	0.000571	CcSEcCtD
Gliclazide—Myalgia—Methylprednisolone—ulcerative colitis	0.000131	0.000571	CcSEcCtD
Gliclazide—Eye disorder—Prednisone—ulcerative colitis	0.000131	0.000571	CcSEcCtD
Gliclazide—Anxiety—Methylprednisolone—ulcerative colitis	0.000131	0.000569	CcSEcCtD
Gliclazide—Tachycardia—Hydrocortisone—ulcerative colitis	0.000131	0.000569	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—DLD—ulcerative colitis	0.000131	0.00173	CbGpPWpGaD
Gliclazide—Rash—Azathioprine—ulcerative colitis	0.00013	0.000567	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.00013	0.000567	CcSEcCtD
Gliclazide—Dermatitis—Azathioprine—ulcerative colitis	0.00013	0.000567	CcSEcCtD
Gliclazide—Flushing—Prednisone—ulcerative colitis	0.00013	0.000567	CcSEcCtD
Gliclazide—Skin disorder—Hydrocortisone—ulcerative colitis	0.00013	0.000566	CcSEcCtD
Gliclazide—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.00013	0.000566	CcSEcCtD
Gliclazide—Ill-defined disorder—Betamethasone—ulcerative colitis	0.00013	0.000566	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	0.00013	0.00173	CbGpPWpGaD
Gliclazide—Discomfort—Triamcinolone—ulcerative colitis	0.00013	0.000566	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—IFNG—ulcerative colitis	0.00013	0.00172	CbGpPWpGaD
Gliclazide—Discomfort—Methylprednisolone—ulcerative colitis	0.00013	0.000564	CcSEcCtD
Gliclazide—Headache—Azathioprine—ulcerative colitis	0.00013	0.000564	CcSEcCtD
Gliclazide—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.00013	0.000564	CcSEcCtD
Gliclazide—Diarrhoea—Mesalazine—ulcerative colitis	0.000129	0.000561	CcSEcCtD
Gliclazide—Dry mouth—Triamcinolone—ulcerative colitis	0.000129	0.00056	CcSEcCtD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—NFKB1—ulcerative colitis	0.000129	0.0017	CbGpPWpGaD
Gliclazide—Angioedema—Dexamethasone—ulcerative colitis	0.000128	0.000558	CcSEcCtD
Gliclazide—Angioedema—Betamethasone—ulcerative colitis	0.000128	0.000558	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—RELA—ulcerative colitis	0.000128	0.0017	CbGpPWpGaD
Gliclazide—Confusional state—Methylprednisolone—ulcerative colitis	0.000127	0.000552	CcSEcCtD
Gliclazide—Malaise—Dexamethasone—ulcerative colitis	0.000127	0.00055	CcSEcCtD
Gliclazide—Malaise—Betamethasone—ulcerative colitis	0.000127	0.00055	CcSEcCtD
Gliclazide—Arrhythmia—Prednisone—ulcerative colitis	0.000125	0.000545	CcSEcCtD
Gliclazide—Infection—Triamcinolone—ulcerative colitis	0.000125	0.000545	CcSEcCtD
Gliclazide—Hypotension—Hydrocortisone—ulcerative colitis	0.000125	0.000545	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.000125	0.00166	CbGpPWpGaD
Gliclazide—Infection—Methylprednisolone—ulcerative colitis	0.000125	0.000544	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	0.000125	0.00166	CbGpPWpGaD
Gliclazide—Dizziness—Mesalazine—ulcerative colitis	0.000125	0.000542	CcSEcCtD
Gliclazide—Insomnia—Prednisolone—ulcerative colitis	0.000124	0.00054	CcSEcCtD
Gliclazide—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000124	0.000537	CcSEcCtD
Gliclazide—Loss of consciousness—Betamethasone—ulcerative colitis	0.000123	0.000536	CcSEcCtD
Gliclazide—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000123	0.000536	CcSEcCtD
Gliclazide—Paraesthesia—Prednisolone—ulcerative colitis	0.000123	0.000536	CcSEcCtD
Gliclazide—Tachycardia—Triamcinolone—ulcerative colitis	0.000123	0.000536	CcSEcCtD
Gliclazide—Mental disorder—Prednisone—ulcerative colitis	0.000123	0.000535	CcSEcCtD
Gliclazide—Nausea—Azathioprine—ulcerative colitis	0.000123	0.000535	CcSEcCtD
Gliclazide—Tachycardia—Methylprednisolone—ulcerative colitis	0.000123	0.000535	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	0.000123	0.00163	CbGpPWpGaD
Gliclazide—Skin disorder—Methylprednisolone—ulcerative colitis	0.000122	0.000532	CcSEcCtD
Gliclazide—Erythema—Prednisone—ulcerative colitis	0.000122	0.000531	CcSEcCtD
Gliclazide—Malnutrition—Prednisone—ulcerative colitis	0.000122	0.000531	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000122	0.000531	CcSEcCtD
Gliclazide—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000122	0.000531	CcSEcCtD
Gliclazide—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000122	0.000529	CcSEcCtD
Gliclazide—Convulsion—Dexamethasone—ulcerative colitis	0.000122	0.000529	CcSEcCtD
Gliclazide—Convulsion—Betamethasone—ulcerative colitis	0.000122	0.000529	CcSEcCtD
Gliclazide—Insomnia—Hydrocortisone—ulcerative colitis	0.000121	0.000527	CcSEcCtD
Gliclazide—Hypertension—Betamethasone—ulcerative colitis	0.000121	0.000527	CcSEcCtD
Gliclazide—Hypertension—Dexamethasone—ulcerative colitis	0.000121	0.000527	CcSEcCtD
Gliclazide—Paraesthesia—Hydrocortisone—ulcerative colitis	0.00012	0.000523	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—CRP—ulcerative colitis	0.00012	0.00159	CbGpPWpGaD
Gliclazide—Vomiting—Mesalazine—ulcerative colitis	0.00012	0.000521	CcSEcCtD
Gliclazide—Myalgia—Dexamethasone—ulcerative colitis	0.000119	0.00052	CcSEcCtD
Gliclazide—Myalgia—Betamethasone—ulcerative colitis	0.000119	0.00052	CcSEcCtD
Gliclazide—Anxiety—Dexamethasone—ulcerative colitis	0.000119	0.000518	CcSEcCtD
Gliclazide—Anxiety—Betamethasone—ulcerative colitis	0.000119	0.000518	CcSEcCtD
Gliclazide—Rash—Mesalazine—ulcerative colitis	0.000119	0.000517	CcSEcCtD
Gliclazide—Dermatitis—Mesalazine—ulcerative colitis	0.000119	0.000516	CcSEcCtD
Gliclazide—Headache—Mesalazine—ulcerative colitis	0.000118	0.000514	CcSEcCtD
Gliclazide—Discomfort—Betamethasone—ulcerative colitis	0.000118	0.000513	CcSEcCtD
Gliclazide—Discomfort—Dexamethasone—ulcerative colitis	0.000118	0.000513	CcSEcCtD
Gliclazide—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000118	0.000513	CcSEcCtD
Gliclazide—Hypotension—Methylprednisolone—ulcerative colitis	0.000118	0.000512	CcSEcCtD
Gliclazide—Pain—Prednisolone—ulcerative colitis	0.000117	0.00051	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	0.000116	0.00154	CbGpPWpGaD
Gliclazide—ALB—Vitamin B12 Metabolism—IL1B—ulcerative colitis	0.000116	0.00154	CbGpPWpGaD
Gliclazide—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000116	0.000503	CcSEcCtD
Gliclazide—Fatigue—Hydrocortisone—ulcerative colitis	0.000116	0.000503	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000115	0.0005	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000115	0.000499	CcSEcCtD
Gliclazide—Pain—Hydrocortisone—ulcerative colitis	0.000115	0.000499	CcSEcCtD
Gliclazide—Insomnia—Triamcinolone—ulcerative colitis	0.000114	0.000496	CcSEcCtD
Gliclazide—Insomnia—Methylprednisolone—ulcerative colitis	0.000114	0.000495	CcSEcCtD
Gliclazide—Infection—Betamethasone—ulcerative colitis	0.000114	0.000495	CcSEcCtD
Gliclazide—Infection—Dexamethasone—ulcerative colitis	0.000114	0.000495	CcSEcCtD
Gliclazide—CYP2C19—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000114	0.00151	CbGpPWpGaD
Gliclazide—Ill-defined disorder—Prednisone—ulcerative colitis	0.000113	0.000493	CcSEcCtD
Gliclazide—Paraesthesia—Triamcinolone—ulcerative colitis	0.000113	0.000493	CcSEcCtD
Gliclazide—Feeling abnormal—Prednisolone—ulcerative colitis	0.000113	0.000492	CcSEcCtD
Gliclazide—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000113	0.000492	CcSEcCtD
Gliclazide—Anaemia—Prednisone—ulcerative colitis	0.000113	0.000491	CcSEcCtD
Gliclazide—Dyspnoea—Triamcinolone—ulcerative colitis	0.000113	0.000489	CcSEcCtD
Gliclazide—Nervous system disorder—Betamethasone—ulcerative colitis	0.000112	0.000488	CcSEcCtD
Gliclazide—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000112	0.000488	CcSEcCtD
Gliclazide—Agitation—Prednisone—ulcerative colitis	0.000112	0.000488	CcSEcCtD
Gliclazide—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000112	0.000488	CcSEcCtD
Gliclazide—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000112	0.000488	CcSEcCtD
Gliclazide—Nausea—Mesalazine—ulcerative colitis	0.000112	0.000487	CcSEcCtD
Gliclazide—Tachycardia—Betamethasone—ulcerative colitis	0.000112	0.000486	CcSEcCtD
Gliclazide—Tachycardia—Dexamethasone—ulcerative colitis	0.000112	0.000486	CcSEcCtD
Gliclazide—Angioedema—Prednisone—ulcerative colitis	0.000112	0.000486	CcSEcCtD
Gliclazide—Dyspepsia—Triamcinolone—ulcerative colitis	0.000111	0.000483	CcSEcCtD
Gliclazide—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000111	0.000482	CcSEcCtD
Gliclazide—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000111	0.000481	CcSEcCtD
Gliclazide—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000111	0.000481	CcSEcCtD
Gliclazide—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.00011	0.00048	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—ICAM1—ulcerative colitis	0.00011	0.00146	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—PTGS1—ulcerative colitis	0.00011	0.00146	CbGpPWpGaD
Gliclazide—Malaise—Prednisone—ulcerative colitis	0.00011	0.000479	CcSEcCtD
Gliclazide—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.00011	0.000477	CcSEcCtD
Gliclazide—Urticaria—Prednisolone—ulcerative colitis	0.000109	0.000474	CcSEcCtD
Gliclazide—Fatigue—Triamcinolone—ulcerative colitis	0.000109	0.000473	CcSEcCtD
Gliclazide—Fatigue—Methylprednisolone—ulcerative colitis	0.000109	0.000472	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	0.000108	0.00143	CbGpPWpGaD
Gliclazide—Pain—Triamcinolone—ulcerative colitis	0.000108	0.000469	CcSEcCtD
Gliclazide—ALB—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000107	0.00142	CbGpPWpGaD
Gliclazide—Loss of consciousness—Prednisone—ulcerative colitis	0.000107	0.000467	CcSEcCtD
Gliclazide—Hypotension—Dexamethasone—ulcerative colitis	0.000107	0.000465	CcSEcCtD
Gliclazide—Hypotension—Betamethasone—ulcerative colitis	0.000107	0.000465	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	0.000107	0.00141	CbGpPWpGaD
Gliclazide—Urticaria—Hydrocortisone—ulcerative colitis	0.000106	0.000463	CcSEcCtD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—IL6—ulcerative colitis	0.000106	0.00141	CbGpPWpGaD
Gliclazide—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000106	0.000461	CcSEcCtD
Gliclazide—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000106	0.000461	CcSEcCtD
Gliclazide—Convulsion—Prednisone—ulcerative colitis	0.000106	0.00046	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—IFNG—ulcerative colitis	0.000106	0.0014	CbGpPWpGaD
Gliclazide—Hypertension—Prednisone—ulcerative colitis	0.000106	0.000459	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000104	0.000454	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000104	0.000454	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—RELA—ulcerative colitis	0.000104	0.00138	CbGpPWpGaD
Gliclazide—Arthralgia—Prednisone—ulcerative colitis	0.000104	0.000452	CcSEcCtD
Gliclazide—Myalgia—Prednisone—ulcerative colitis	0.000104	0.000452	CcSEcCtD
Gliclazide—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000104	0.000452	CcSEcCtD
Gliclazide—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000104	0.000451	CcSEcCtD
Gliclazide—Anxiety—Prednisone—ulcerative colitis	0.000104	0.000451	CcSEcCtD
Gliclazide—Insomnia—Dexamethasone—ulcerative colitis	0.000104	0.00045	CcSEcCtD
Gliclazide—Insomnia—Betamethasone—ulcerative colitis	0.000104	0.00045	CcSEcCtD
Gliclazide—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	0.000104	0.00137	CbGpPWpGaD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000103	0.000449	CcSEcCtD
Gliclazide—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000103	0.000448	CcSEcCtD
Gliclazide—Paraesthesia—Dexamethasone—ulcerative colitis	0.000103	0.000447	CcSEcCtD
Gliclazide—Paraesthesia—Betamethasone—ulcerative colitis	0.000103	0.000447	CcSEcCtD
Gliclazide—Discomfort—Prednisone—ulcerative colitis	0.000103	0.000447	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	0.000101	0.00134	CbGpPWpGaD
Gliclazide—Hypersensitivity—Prednisolone—ulcerative colitis	0.000101	0.00044	CcSEcCtD
Gliclazide—Dyspepsia—Dexamethasone—ulcerative colitis	0.000101	0.000438	CcSEcCtD
Gliclazide—Dyspepsia—Betamethasone—ulcerative colitis	0.000101	0.000438	CcSEcCtD
Gliclazide—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	0.000101	0.00133	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—IL6—ulcerative colitis	0.0001	0.00133	CbGpPWpGaD
Gliclazide—Urticaria—Triamcinolone—ulcerative colitis	0.0001	0.000436	CcSEcCtD
Gliclazide—Urticaria—Methylprednisolone—ulcerative colitis	0.0001	0.000435	CcSEcCtD
Gliclazide—Body temperature increased—Triamcinolone—ulcerative colitis	9.98e-05	0.000434	CcSEcCtD
Gliclazide—Abdominal pain—Methylprednisolone—ulcerative colitis	9.96e-05	0.000433	CcSEcCtD
Gliclazide—Infection—Prednisone—ulcerative colitis	9.91e-05	0.000431	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.89e-05	0.00043	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.89e-05	0.00043	CcSEcCtD
Gliclazide—Hypersensitivity—Hydrocortisone—ulcerative colitis	9.88e-05	0.000429	CcSEcCtD
Gliclazide—Fatigue—Betamethasone—ulcerative colitis	9.87e-05	0.000429	CcSEcCtD
Gliclazide—Fatigue—Dexamethasone—ulcerative colitis	9.87e-05	0.000429	CcSEcCtD
Gliclazide—Pain—Betamethasone—ulcerative colitis	9.79e-05	0.000426	CcSEcCtD
Gliclazide—Pain—Dexamethasone—ulcerative colitis	9.79e-05	0.000426	CcSEcCtD
Gliclazide—Nervous system disorder—Prednisone—ulcerative colitis	9.78e-05	0.000425	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—RELA—ulcerative colitis	9.75e-05	0.00129	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	9.74e-05	0.00129	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—TNF—ulcerative colitis	9.74e-05	0.00129	CbGpPWpGaD
Gliclazide—Tachycardia—Prednisone—ulcerative colitis	9.73e-05	0.000423	CcSEcCtD
Gliclazide—Skin disorder—Prednisone—ulcerative colitis	9.69e-05	0.000421	CcSEcCtD
Gliclazide—Hyperhidrosis—Prednisone—ulcerative colitis	9.64e-05	0.000419	CcSEcCtD
Gliclazide—Asthenia—Hydrocortisone—ulcerative colitis	9.62e-05	0.000418	CcSEcCtD
Gliclazide—Pruritus—Hydrocortisone—ulcerative colitis	9.48e-05	0.000412	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—SEL1L—ulcerative colitis	9.48e-05	0.00126	CbGpPWpGaD
Gliclazide—Feeling abnormal—Dexamethasone—ulcerative colitis	9.44e-05	0.00041	CcSEcCtD
Gliclazide—Feeling abnormal—Betamethasone—ulcerative colitis	9.44e-05	0.00041	CcSEcCtD
Gliclazide—ALB—Folate Metabolism—IL1B—ulcerative colitis	9.43e-05	0.00125	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL2—ulcerative colitis	9.39e-05	0.00125	CbGpPWpGaD
Gliclazide—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.37e-05	0.000407	CcSEcCtD
Gliclazide—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.37e-05	0.000407	CcSEcCtD
Gliclazide—Hypersensitivity—Triamcinolone—ulcerative colitis	9.3e-05	0.000404	CcSEcCtD
Gliclazide—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.28e-05	0.000404	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—CXCL8—ulcerative colitis	9.19e-05	0.00122	CbGpPWpGaD
Gliclazide—Diarrhoea—Hydrocortisone—ulcerative colitis	9.17e-05	0.000399	CcSEcCtD
Gliclazide—Urticaria—Dexamethasone—ulcerative colitis	9.1e-05	0.000396	CcSEcCtD
Gliclazide—Urticaria—Betamethasone—ulcerative colitis	9.1e-05	0.000396	CcSEcCtD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.09e-05	0.00121	CbGpPWpGaD
Gliclazide—Musculoskeletal discomfort—Prednisone—ulcerative colitis	9.09e-05	0.000395	CcSEcCtD
Gliclazide—Dizziness—Prednisolone—ulcerative colitis	9.08e-05	0.000395	CcSEcCtD
Gliclazide—Asthenia—Triamcinolone—ulcerative colitis	9.06e-05	0.000394	CcSEcCtD
Gliclazide—ALB—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	9.05e-05	0.0012	CbGpPWpGaD
Gliclazide—Body temperature increased—Betamethasone—ulcerative colitis	9.05e-05	0.000394	CcSEcCtD
Gliclazide—Body temperature increased—Dexamethasone—ulcerative colitis	9.05e-05	0.000394	CcSEcCtD
Gliclazide—Abdominal pain—Dexamethasone—ulcerative colitis	9.05e-05	0.000394	CcSEcCtD
Gliclazide—Abdominal pain—Betamethasone—ulcerative colitis	9.05e-05	0.000394	CcSEcCtD
Gliclazide—Asthenia—Methylprednisolone—ulcerative colitis	9.04e-05	0.000393	CcSEcCtD
Gliclazide—Insomnia—Prednisone—ulcerative colitis	9.02e-05	0.000392	CcSEcCtD
Gliclazide—Paraesthesia—Prednisone—ulcerative colitis	8.96e-05	0.000389	CcSEcCtD
Gliclazide—Pruritus—Triamcinolone—ulcerative colitis	8.93e-05	0.000388	CcSEcCtD
Gliclazide—Pruritus—Methylprednisolone—ulcerative colitis	8.91e-05	0.000387	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	8.87e-05	0.00118	CbGpPWpGaD
Gliclazide—Dizziness—Hydrocortisone—ulcerative colitis	8.86e-05	0.000385	CcSEcCtD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	8.81e-05	0.00117	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—NFKB1—ulcerative colitis	8.79e-05	0.00117	CbGpPWpGaD
Gliclazide—Dyspepsia—Prednisone—ulcerative colitis	8.78e-05	0.000382	CcSEcCtD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	8.77e-05	0.00116	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	8.77e-05	0.00116	CbGpPWpGaD
Gliclazide—Rash—Prednisolone—ulcerative colitis	8.65e-05	0.000376	CcSEcCtD
Gliclazide—Dermatitis—Prednisolone—ulcerative colitis	8.65e-05	0.000376	CcSEcCtD
Gliclazide—Diarrhoea—Methylprednisolone—ulcerative colitis	8.62e-05	0.000375	CcSEcCtD
Gliclazide—Fatigue—Prednisone—ulcerative colitis	8.6e-05	0.000374	CcSEcCtD
Gliclazide—Headache—Prednisolone—ulcerative colitis	8.6e-05	0.000374	CcSEcCtD
Gliclazide—VEGFA—Axon guidance—JAK2—ulcerative colitis	8.54e-05	0.00113	CbGpPWpGaD
Gliclazide—Constipation—Prednisone—ulcerative colitis	8.53e-05	0.000371	CcSEcCtD
Gliclazide—Vomiting—Hydrocortisone—ulcerative colitis	8.52e-05	0.000371	CcSEcCtD
Gliclazide—VEGFA—Hemostasis—MMP1—ulcerative colitis	8.49e-05	0.00113	CbGpPWpGaD
Gliclazide—Rash—Hydrocortisone—ulcerative colitis	8.45e-05	0.000368	CcSEcCtD
Gliclazide—Dermatitis—Hydrocortisone—ulcerative colitis	8.44e-05	0.000367	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—TNF—ulcerative colitis	8.41e-05	0.00112	CbGpPWpGaD
Gliclazide—Headache—Hydrocortisone—ulcerative colitis	8.4e-05	0.000365	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—IFNG—ulcerative colitis	8.4e-05	0.00111	CbGpPWpGaD
Gliclazide—Dizziness—Triamcinolone—ulcerative colitis	8.35e-05	0.000363	CcSEcCtD
Gliclazide—Dizziness—Methylprednisolone—ulcerative colitis	8.33e-05	0.000362	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—RELA—ulcerative colitis	8.28e-05	0.0011	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	8.28e-05	0.0011	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—NFKB1—ulcerative colitis	8.22e-05	0.00109	CbGpPWpGaD
Gliclazide—Feeling abnormal—Prednisone—ulcerative colitis	8.22e-05	0.000357	CcSEcCtD
Gliclazide—Asthenia—Dexamethasone—ulcerative colitis	8.22e-05	0.000357	CcSEcCtD
Gliclazide—Asthenia—Betamethasone—ulcerative colitis	8.22e-05	0.000357	CcSEcCtD
Gliclazide—Gastrointestinal pain—Prednisone—ulcerative colitis	8.16e-05	0.000355	CcSEcCtD
Gliclazide—Nausea—Prednisolone—ulcerative colitis	8.15e-05	0.000355	CcSEcCtD
Gliclazide—Pruritus—Dexamethasone—ulcerative colitis	8.1e-05	0.000352	CcSEcCtD
Gliclazide—Pruritus—Betamethasone—ulcerative colitis	8.1e-05	0.000352	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—PTGS2—ulcerative colitis	8.05e-05	0.00107	CbGpPWpGaD
Gliclazide—Vomiting—Triamcinolone—ulcerative colitis	8.03e-05	0.000349	CcSEcCtD
Gliclazide—Vomiting—Methylprednisolone—ulcerative colitis	8.01e-05	0.000348	CcSEcCtD
Gliclazide—Nausea—Hydrocortisone—ulcerative colitis	7.96e-05	0.000346	CcSEcCtD
Gliclazide—Rash—Triamcinolone—ulcerative colitis	7.96e-05	0.000346	CcSEcCtD
Gliclazide—Dermatitis—Triamcinolone—ulcerative colitis	7.95e-05	0.000346	CcSEcCtD
Gliclazide—Rash—Methylprednisolone—ulcerative colitis	7.94e-05	0.000345	CcSEcCtD
Gliclazide—Dermatitis—Methylprednisolone—ulcerative colitis	7.93e-05	0.000345	CcSEcCtD
Gliclazide—Urticaria—Prednisone—ulcerative colitis	7.92e-05	0.000345	CcSEcCtD
Gliclazide—Headache—Triamcinolone—ulcerative colitis	7.91e-05	0.000344	CcSEcCtD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	7.89e-05	0.00105	CbGpPWpGaD
Gliclazide—Headache—Methylprednisolone—ulcerative colitis	7.89e-05	0.000343	CcSEcCtD
Gliclazide—Body temperature increased—Prednisone—ulcerative colitis	7.88e-05	0.000343	CcSEcCtD
Gliclazide—Abdominal pain—Prednisone—ulcerative colitis	7.88e-05	0.000343	CcSEcCtD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—IL6—ulcerative colitis	7.86e-05	0.00104	CbGpPWpGaD
Gliclazide—Diarrhoea—Dexamethasone—ulcerative colitis	7.84e-05	0.000341	CcSEcCtD
Gliclazide—Diarrhoea—Betamethasone—ulcerative colitis	7.84e-05	0.000341	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—CXCR1—ulcerative colitis	7.81e-05	0.00104	CbGpPWpGaD
Gliclazide—Dizziness—Dexamethasone—ulcerative colitis	7.57e-05	0.000329	CcSEcCtD
Gliclazide—Dizziness—Betamethasone—ulcerative colitis	7.57e-05	0.000329	CcSEcCtD
Gliclazide—Nausea—Triamcinolone—ulcerative colitis	7.5e-05	0.000326	CcSEcCtD
Gliclazide—ALB—Selenium Micronutrient Network—IL1B—ulcerative colitis	7.49e-05	0.000993	CbGpPWpGaD
Gliclazide—Nausea—Methylprednisolone—ulcerative colitis	7.48e-05	0.000325	CcSEcCtD
Gliclazide—VEGFA—Cellular responses to stress—STAT3—ulcerative colitis	7.39e-05	0.00098	CbGpPWpGaD
Gliclazide—Hypersensitivity—Prednisone—ulcerative colitis	7.35e-05	0.00032	CcSEcCtD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.3e-05	0.000969	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—PPARG—ulcerative colitis	7.29e-05	0.000967	CbGpPWpGaD
Gliclazide—Vomiting—Dexamethasone—ulcerative colitis	7.28e-05	0.000317	CcSEcCtD
Gliclazide—Vomiting—Betamethasone—ulcerative colitis	7.28e-05	0.000317	CcSEcCtD
Gliclazide—Rash—Dexamethasone—ulcerative colitis	7.22e-05	0.000314	CcSEcCtD
Gliclazide—Rash—Betamethasone—ulcerative colitis	7.22e-05	0.000314	CcSEcCtD
Gliclazide—Dermatitis—Dexamethasone—ulcerative colitis	7.21e-05	0.000314	CcSEcCtD
Gliclazide—Dermatitis—Betamethasone—ulcerative colitis	7.21e-05	0.000314	CcSEcCtD
Gliclazide—Headache—Betamethasone—ulcerative colitis	7.17e-05	0.000312	CcSEcCtD
Gliclazide—Headache—Dexamethasone—ulcerative colitis	7.17e-05	0.000312	CcSEcCtD
Gliclazide—Asthenia—Prednisone—ulcerative colitis	7.16e-05	0.000311	CcSEcCtD
Gliclazide—Pruritus—Prednisone—ulcerative colitis	7.06e-05	0.000307	CcSEcCtD
Gliclazide—VEGFA—Axon guidance—MMP9—ulcerative colitis	7.05e-05	0.000935	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	6.99e-05	0.000927	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL20—ulcerative colitis	6.85e-05	0.000909	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TNF—ulcerative colitis	6.84e-05	0.000907	CbGpPWpGaD
Gliclazide—Diarrhoea—Prednisone—ulcerative colitis	6.82e-05	0.000297	CcSEcCtD
Gliclazide—Nausea—Betamethasone—ulcerative colitis	6.8e-05	0.000296	CcSEcCtD
Gliclazide—Nausea—Dexamethasone—ulcerative colitis	6.8e-05	0.000296	CcSEcCtD
Gliclazide—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	6.79e-05	0.0009	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—GNA12—ulcerative colitis	6.71e-05	0.00089	CbGpPWpGaD
Gliclazide—Dizziness—Prednisone—ulcerative colitis	6.6e-05	0.000287	CcSEcCtD
Gliclazide—ALB—Hemostasis—ITGAL—ulcerative colitis	6.58e-05	0.000873	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS1—ulcerative colitis	6.52e-05	0.000864	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GNA12—ulcerative colitis	6.44e-05	0.000855	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—ALB—ulcerative colitis	6.43e-05	0.000853	CbGpPWpGaD
Gliclazide—Vomiting—Prednisone—ulcerative colitis	6.34e-05	0.000276	CcSEcCtD
Gliclazide—KCNJ11—Metabolism—PTGS1—ulcerative colitis	6.32e-05	0.000838	CbGpPWpGaD
Gliclazide—Rash—Prednisone—ulcerative colitis	6.29e-05	0.000273	CcSEcCtD
Gliclazide—Dermatitis—Prednisone—ulcerative colitis	6.28e-05	0.000273	CcSEcCtD
Gliclazide—ALB—Platelet degranulation—TGFB1—ulcerative colitis	6.28e-05	0.000833	CbGpPWpGaD
Gliclazide—Headache—Prednisone—ulcerative colitis	6.25e-05	0.000272	CcSEcCtD
Gliclazide—VEGFA—Signaling Pathways—CXCR2—ulcerative colitis	6.11e-05	0.00081	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—JAK2—ulcerative colitis	6.1e-05	0.000809	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.1e-05	0.000808	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—ulcerative colitis	6.03e-05	0.0008	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	5.98e-05	0.000794	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—JAK2—ulcerative colitis	5.98e-05	0.000793	CbGpPWpGaD
Gliclazide—Nausea—Prednisone—ulcerative colitis	5.92e-05	0.000258	CcSEcCtD
Gliclazide—VEGFA—Developmental Biology—RELA—ulcerative colitis	5.9e-05	0.000783	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CALM3—ulcerative colitis	5.87e-05	0.000778	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCR6—ulcerative colitis	5.74e-05	0.000762	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CALM3—ulcerative colitis	5.69e-05	0.000755	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—ulcerative colitis	5.64e-05	0.000748	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—ulcerative colitis	5.52e-05	0.000732	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	5.46e-05	0.000724	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MAML2—ulcerative colitis	5.44e-05	0.000722	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	5.43e-05	0.000721	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IL2—ulcerative colitis	5.22e-05	0.000692	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—ulcerative colitis	5.16e-05	0.000684	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PTGER4—ulcerative colitis	5.06e-05	0.000671	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CHP1—ulcerative colitis	5.04e-05	0.000668	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—MMP9—ulcerative colitis	5.03e-05	0.000668	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—NFKB1—ulcerative colitis	4.98e-05	0.00066	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.72e-05	0.000626	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CALM3—ulcerative colitis	4.67e-05	0.000619	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GHRL—ulcerative colitis	4.63e-05	0.000614	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ABCB1—ulcerative colitis	4.56e-05	0.000605	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CHP1—ulcerative colitis	4.52e-05	0.0006	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CALM3—ulcerative colitis	4.48e-05	0.000595	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—STAT3—ulcerative colitis	4.48e-05	0.000594	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ABCB1—ulcerative colitis	4.43e-05	0.000587	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RIPK2—ulcerative colitis	4.42e-05	0.000586	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	4.39e-05	0.000582	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—ulcerative colitis	4.38e-05	0.000581	CbGpPWpGaD
Gliclazide—ALB—Metabolism—DLD—ulcerative colitis	4.35e-05	0.000577	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ADCY5—ulcerative colitis	4.26e-05	0.000565	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.24e-05	0.000562	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TGFB1—ulcerative colitis	4.15e-05	0.00055	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ADCY5—ulcerative colitis	4.13e-05	0.000548	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CHP1—ulcerative colitis	4.12e-05	0.000547	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	4.09e-05	0.000543	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TGFB1—ulcerative colitis	4.07e-05	0.00054	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—DLD—ulcerative colitis	3.9e-05	0.000518	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—ulcerative colitis	3.87e-05	0.000514	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.86e-05	0.000512	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADRB2—ulcerative colitis	3.83e-05	0.000508	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	3.57e-05	0.000474	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DLD—ulcerative colitis	3.56e-05	0.000472	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—ulcerative colitis	3.35e-05	0.000444	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ADCY5—ulcerative colitis	3.25e-05	0.000431	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PPARG—ulcerative colitis	3.18e-05	0.000421	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.14e-05	0.000417	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—ulcerative colitis	3.13e-05	0.000415	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PPARG—ulcerative colitis	3.08e-05	0.000408	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—MMP1—ulcerative colitis	3e-05	0.000397	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.93e-05	0.000389	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALB—ulcerative colitis	2.86e-05	0.000379	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.79e-05	0.000369	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALB—ulcerative colitis	2.77e-05	0.000367	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—ulcerative colitis	2.5e-05	0.000331	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—ulcerative colitis	2.42e-05	0.000321	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.3e-05	0.000305	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—JAK2—ulcerative colitis	2.11e-05	0.00028	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS1—ulcerative colitis	2.1e-05	0.000279	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.06e-05	0.000274	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—JAK2—ulcerative colitis	2.03e-05	0.000269	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RELA—ulcerative colitis	1.96e-05	0.00026	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CALM3—ulcerative colitis	1.89e-05	0.000251	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS1—ulcerative colitis	1.89e-05	0.00025	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.88e-05	0.00025	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.86e-05	0.000246	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CXCL8—ulcerative colitis	1.85e-05	0.000245	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IL2—ulcerative colitis	1.84e-05	0.000244	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.81e-05	0.00024	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL2—ulcerative colitis	1.77e-05	0.000235	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS1—ulcerative colitis	1.72e-05	0.000228	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CALM3—ulcerative colitis	1.7e-05	0.000225	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.69e-05	0.000224	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MMP9—ulcerative colitis	1.67e-05	0.000222	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NFKB1—ulcerative colitis	1.66e-05	0.00022	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.62e-05	0.000215	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CALM3—ulcerative colitis	1.55e-05	0.000205	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—STAT3—ulcerative colitis	1.49e-05	0.000197	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.48e-05	0.000196	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCB1—ulcerative colitis	1.47e-05	0.000195	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—ulcerative colitis	1.44e-05	0.00019	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—ulcerative colitis	1.38e-05	0.000183	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ADCY5—ulcerative colitis	1.37e-05	0.000182	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCB1—ulcerative colitis	1.32e-05	0.000175	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ADCY5—ulcerative colitis	1.23e-05	0.000163	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.2e-05	0.00016	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—ulcerative colitis	1.18e-05	0.000157	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—ulcerative colitis	1.14e-05	0.000151	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.12e-05	0.000149	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—ulcerative colitis	1.04e-05	0.000138	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARG—ulcerative colitis	1.02e-05	0.000136	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARG—ulcerative colitis	9.19e-06	0.000122	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARG—ulcerative colitis	8.38e-06	0.000111	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALB—ulcerative colitis	8.26e-06	0.00011	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—ulcerative colitis	8.05e-06	0.000107	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALB—ulcerative colitis	7.53e-06	9.99e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—ulcerative colitis	7.23e-06	9.59e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—ulcerative colitis	6.59e-06	8.74e-05	CbGpPWpGaD
